Next Generation Sequencing (NGS) Market Trends, Insights and Future Outlook 2024–2031

The Next Generation Sequencing (NGS) Market sector is undergoing rapid transformation, with significant growth and innovations expected by 2031. In-depth market research offers a thorough analysis of market size, share, and emerging trends, providing essential insights into its expansion potential. The report explores market segmentation and definitions, emphasizing key components and growth drivers. Through the use of SWOT and PESTEL analyses, it evaluates the sector’s strengths, weaknesses, opportunities, and threats, while considering political, economic, social, technological, environmental, and legal influences. Expert evaluations of competitor strategies and recent developments shed light on geographical trends and forecast the market’s future direction, creating a solid framework for strategic planning and investment decisions.

Get a Sample PDF of Report – https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-next-generation-sequencing-ngs-market

Which are the top companies operating in the Next Generation Sequencing (NGS) Market?

The report profiles noticeable organizations working in the water purifier showcase and the triumphant methodologies received by them. It likewise reveals insights about the share held by each organization and their contribution to the market’s extension. This Global Next Generation Sequencing (NGS) Market report provides the information of the Top Companies in Next Generation Sequencing (NGS) Market in the market their business strategy, financial situation etc.

Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Merck KGaA, Charles River Laboratories, Revvity, Promega Corporation., Agilent Technologies, Inc., Takara Bio Inc., Eurofins Scientific, Hamilton Company, BGI, Azenta US, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., PacBio., Macrogen, Inc., Gilson Incorporated, New England Biolabs, Oxford Nanopore Technologies plc., LGC Biosearch Technologies, PCR Biosystems, ACT Genomics, Quantabio, DNASTAR, and NimaGen. among others

Report Scope and Market Segmentation

Which are the driving factors of the Next Generation Sequencing (NGS) Market?

The driving factors of the Next Generation Sequencing (NGS) Market are multifaceted and crucial for its growth and development. Technological advancements play a significant role by enhancing product efficiency, reducing costs, and introducing innovative features that cater to evolving consumer demands. Rising consumer interest and demand for keyword-related products and services further fuel market expansion. Favorable economic conditions, including increased disposable incomes, enable higher consumer spending, which benefits the market. Supportive regulatory environments, with policies that provide incentives and subsidies, also encourage growth, while globalization opens new opportunities by expanding market reach and international trade.

Next Generation Sequencing (NGS) Market – Competitive and Segmentation Analysis:

**Segments**

– On the basis of product & services, the Next Generation Sequencing (NGS) market can be segmented into reagents & consumables, sequencing services, instruments, and software.
– By technology, the market can be divided into sequencing by synthesis, ion semiconductor sequencing, single-molecule realtime (SMRT) sequencing, nanopore sequencing, and others.
– When it comes to application, the NGS market encompasses segments such as diagnostics, drug discovery, agricultural & animal research, and others.
– Based on end-users, the market is categorized into academic research institutes, pharmaceutical & biotechnology companies, hospitals & clinics, and others.

**Market Players**

– Illumina, Inc.
– Thermo Fisher Scientific Inc.
– Oxford Nanopore Technologies
– Pacific Biosciences of California, Inc.
– BGI Group
– Qiagen
– F. Hoffmann-La Roche Ltd
– Agilent Technologies
– PerkinElmer Inc.
– Eurofins Genomics
– Macrogen, Inc.
– GATC Biotech AG
– Bio-Rad Laboratories, Inc.

The global Next Generation Sequencing (NGS) market is poised for significant growth by 2031. The market is experiencing robust expansion propelled by technological advancements, rising demand for precision medicine, and increasing applications of NGS in various sectors. With the evolution of sequencing technologies and the decreasing cost of sequencing, the NGS market is witnessing a surge in adoption across different end-user segments. The product & services segment, including reagents & consumables, sequencing services, instruments, and software, is expected to exhibit substantial growth. Among the key technologies driving market growth, sequencing by synthesis and ion semiconductor sequencing lead the pack, followed closely by single-molecule realtime (SMRT) sequencing and nanopore sequencing. Furthermore, the application of NGS in diagnostics, drug discovery, agricultural & animal research is anticipated to drive market expansion in the forecast period. Key players in the NGSThe Next Generation Sequencing (NGS) market is witnessing a transformative era with tremendous growth potential as it enters the new decade. The market segmentation based on product & services offers a comprehensive view of the diverse offerings that cater to the unique needs of customers. Reagents & consumables form a crucial segment as they are fundamental components in the sequencing process, ensuring accurate and reliable results. Sequencing services are gaining traction due to the convenience they offer to end-users who prefer outsourcing sequencing tasks. Instruments play a vital role in the NGS workflow, providing the necessary hardware for sequencing processes, while software solutions are essential for data analysis, interpretation, and visualization.

Technological segmentation highlights the cutting-edge innovations driving the NGS market forward. Sequencing by synthesis and ion semiconductor sequencing are prominent technologies known for their accuracy, speed, and scalability, making them preferred choices among researchers and industry players alike. Single-molecule realtime (SMRT) sequencing and nanopore sequencing technologies are on the rise, offering advantages such as long-read sequencing capabilities and real-time data acquisition. These technologies are poised to revolutionize the sequencing landscape and open up new possibilities for genomic research and applications.

The application segments in the NGS market showcase the versatility and wide-ranging impact of this technology across various industries. Diagnostics is a key application area where NGS plays a crucial role in enabling precision medicine, personalized treatments, and disease management strategies. Drug discovery benefits from NGS technologies by accelerating the identification of therapeutic targets, biomarkers, and drug response mechanisms. Agricultural & animal research segments leverage NGS for crop improvement, livestock breeding, biodiversity studies, and understanding genetic traits that impact food production and animal health.

End-users of NGS technologies represent a diverse set of organizations that drive demand and innovation in the market. Academic research institutes form a foundational segment that explores the frontiers of genomics, transcriptomics, epigenomics, and other areas of biological research. Pharmaceutical & biotechnology companies utilize NGS for drug development, clinical trials, and**Market Players**

– Illumina, Inc.
– Thermo Fisher Scientific Inc.
– QIAGEN
– Merck KGaA
– Charles River Laboratories
– Revvity
– Promega Corporation.
– Agilent Technologies, Inc.
– Takara Bio Inc.
– Eurofins Scientific
– Hamilton Company
– BGI
– Azenta US, Inc.
– Beckman Coulter, Inc.
– Bio-Rad Laboratories, Inc.
– PacBio.
– Macrogen, Inc.
– Gilson Incorporated
– New England Biolabs
– Oxford Nanopore Technologies plc.
– LGC Biosearch Technologies
– PCR Biosystems
– ACT Genomics
– Quantabio
– DNASTAR
– NimaGen

The Next Generation Sequencing (NGS) market is witnessing a transformative era with tremendous growth potential as it enters the new decade. The market segmentation based on product & services offers a comprehensive view of the diverse offerings that cater to the unique needs of customers. Reagents & consumables form a crucial segment as they are fundamental components in the sequencing process, ensuring accurate and reliable results. Sequencing services are gaining traction due to the convenience they offer to end-users who prefer outsourcing sequencing tasks. Instruments play a vital role in the NGS workflow, providing the necessary hardware for sequencing processes, while software solutions are essential for data analysis, interpretation, and visualization.

Technological segmentation highlights the cutting-edge innovations driving the NGS market forward

Explore Further Details about This Research Next Generation Sequencing (NGS) Market Report https://www.databridgemarketresearch.com/reports/global-next-generation-sequencing-ngs-market

Key Benefits for Industry Participants and Stakeholders: –

Industry drivers, trends, restraints, and opportunities are covered in the study.
Neutral perspective on the Next Generation Sequencing (NGS) Market scenario
Recent industry growth and new developments
Competitive landscape and strategies of key companies
The Historical, current, and estimated Next Generation Sequencing (NGS) Market size in terms of value and size
In-depth, comprehensive analysis and forecasting of the Next Generation Sequencing (NGS) Market

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2024-2031) of the following regions are covered in Chapters

The countries covered in the Next Generation Sequencing (NGS) Market report are U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of the Middle East and Africa.

Key Questions Answered:

1. What is the Next Generation Sequencing (NGS) Market?

2. How big is the Next Generation Sequencing (NGS) Market?

3. What is the growth rate of the Next Generation Sequencing (NGS) Market?

4. What are the key drivers of the Next Generation Sequencing (NGS) Market?

5. Which region dominates the Next Generation Sequencing (NGS) Market?

6. Who are the major players in the Next Generation Sequencing (NGS) Market?

7. What segments are included in the Next Generation Sequencing (NGS) Market?

8. What are the challenges facing the Next Generation Sequencing (NGS) Market?

9. What is the future outlook for the Next Generation Sequencing (NGS) Market?

10. How can companies benefit from the Next Generation Sequencing (NGS) Market?

Browse More Reports:

Data Bridge Market Research:

Today’s trends are a great way to predict future events!

Data Bridge Market Research is a market research and consulting company that stands out for its innovative and distinctive approach, as well as its unmatched resilience and integrated methods. We are dedicated to identifying the best market opportunities, and providing insightful information that will help your business thrive in the marketplace. Data Bridge offers tailored solutions to complex business challenges. This facilitates a smooth decision-making process. Data Bridge was founded in Pune in 2015. It is the product of deep wisdom and experience.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 978

Email:- corporatesales@databridgemarketresearch.com

Next Generation Sequencing (NGS) Market Trends, Insights and Future Outlook 2024–2031

Report Scope and Market Segmentation

Key Benefits for Industry Participants and Stakeholders: –

Leave a ReplyCancel Reply